Author(s): Maryam Abdul Kareem Mahmoud, Nagam Khudhair


DOI: 10.52711/0974-360X.2023.00594   

Address: Maryam Abdul Kareem Mahmoud, Nagam Khudhair
Department of Biology, College of Education for Women, University of Anbar, Anbar, Iraq.
*Corresponding Author

Published In:   Volume - 16,      Issue - 8,     Year - 2023

COVID-19 virus caused by severe acute respiratory syndrome (SARS-Cov-2) poses a great threat to human life and public health as it enters the body through ACE2 receptors in lung and spreads through respiratory droplets and close contact. The present study aimed to investigate the role of ACE2 and some biomarkers of COVID-19 patients and vaccine recipients. In total , 80 samples divided into 4 groups (healthy, Patient , healthy vaccinated, Patient vaccinated) were studied, with 10 males and 10 females for each group. RNA was extracted from blood and ACE2 gene expression was measured by qRT-PCR , as well as some biomarkers were measured, including CRP, D.dimer, LDH, Ferritin, Urea, and Creatinine, for all study groups. The results also showed that there were significant differences at the level (P = 0.05) of some biochemical variables in males and females in the healthy group, and in the group of patients, and the group of patients receiving the vaccine, the values of vital signs increased to predict the severity of infection, as for kidney functions, which included (Urea, Creatinine). The results showed a high significant difference of Urea level in females compared to males in the healthy and patients groups at the level (P = 0.05), and the results of Creatinine showed a significant difference for males in the patients group at the level (P = 0.05) compared to females. Significant differences for females at the level (P = 0.05) compared to males in the group of those who received the vaccine, the virus caused kidney impairment in severe cases due to its binding to ACE2 found in kidney tubes, causing tissue and kidney damage in general due to the high level of both creatinine urea, and there is a high positive significant relationship between the angiotensin-converting enzyme ACE2 and some biomarkers in cases of Covid-19 and between the biomarkers each other.

Cite this article:
Maryam Abdul Kareem Mahmoud, Nagam Khudhair. Gene expression of ACE2 gene in patients infected with COVID-19 and comparing them with vaccine recipients. Research Journal of Pharmacy and Technology 2023; 16(8):3601-7. doi: 10.52711/0974-360X.2023.00594

Maryam Abdul Kareem Mahmoud, Nagam Khudhair. Gene expression of ACE2 gene in patients infected with COVID-19 and comparing them with vaccine recipients. Research Journal of Pharmacy and Technology 2023; 16(8):3601-7. doi: 10.52711/0974-360X.2023.00594   Available on:

1.    Lai, C.-C. et al. Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J. Microbiol. Immunol. Infect. 2020; 53: 404–412 (2020).
2.    Valiente, C. et al. Psychological adjustment in Spain during the COVID-19 pandemic: positive and negative mental health outcomes in the general population. Span. J. Psychol. 2021; 24.
3.    Nande, A., Adlam, B., Sheen, J., Levy, M. Z. and Hill, A. L. Dynamics of COVID-19 under social distancing measures are driven by transmission network structure. PLoS Comput. Biol. 2021; 17: e1008684. DOI:
4.    Tian, J. et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020; 21: 893–903.
5.    Peng, L. et al. SARS‐CoV‐2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens. J. Med. Virol. 2020; 92: 1676–1680.
6.    Pereira, M. A. M. et al. Laboratory findings in SARS-CoV-2 infections: State of the art. Rev. Assoc. Med. Bras. 2020; 66: 1152–1156.
7.    Ji, H.-L., Zhao, R., Matalon, S. and Matthay, M. A. Elevated plasmin (ogen) as a common risk factor for COVID-19 susceptibility. Physiol. Rev. 2020.
8.    Naqvi, A. A. T. et al. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach. Biochim. Biophys. Acta (BBA)-Molecular Basis Dis. 2020; 1866: 165878.
9.    Jain, R. S., Jain, T. G. and Ishikar, S. K. Impact of COVID-19 on changing habits and health issues of the public. Asian J. Manag. 2020; 11: 524–528. DOI : 10.5958/2321-5763.2020.00077.3.
10.    Funk, C. D., Laferrière, C. and Ardakani, A. A snapshot of the global race for vaccines targeting SARS-CoV-2 and the COVID-19 pandemic. Front. Pharmacol. 2020; 11: 937.
11.    Kim, Y. C., Dema, B. and Reyes-Sandoval, A. COVID-19 vaccines: breaking record times to first-in-human trials. NPJ Vaccines. 2020; 5: 1–3.
12.    Ayedee, N. and Kumar, A. Indian Education System and growing number of online Conferences: Scenario under COVID-19. Asian J. Manag. 2020; 11: 395–401. DOI: 10.5958/2321-5763.2020.00060.8.
13.    Sette, A. and Crotty, S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021; 184: 861–880.
14.    Toshniwal, A. and Narendran, R. An intertwined approach to workplace happiness, workplace motivation and workplace stress: A study on COVID-19 lockdown. Asian J. Manag. 2020; 11: 407–412. DOI: 10.5958/2321-5763.2020.00062.1.
15.    Leslie, M. T cells found in coronavirus patients ‘bode well’for long-term immunity. at 2020. DOI: 10.1126/science.368.6493.809.
16.    Sarkar, N., Mandal, B. K. and Paul, S. Activity, Effect on Human and Salvation from effect of COVID-19. Strain. 2021; 229: 103. DOI: 10.52711/2321-5763.2021.00035.
17.    Livak, K. J. and Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001; 25: 402–408.
18.    Steel, R. G. D. and Torrie, J. H. Principles and procedures of statistics, a biometrical approach. (McGraw-Hill Kogakusha, Ltd., 1980). DOI: 10.51721/2621-5853.21980.00043.
19.    Fernández-Atucha, A. et al. Sex differences in the aging pattern of renin–angiotensin system serum peptidases. Biol. Sex Differ. 2017; 8: 1–8.
20.    Bernardi, S. et al. Sex differences in proatherogenic cytokine levels. Int. J. Mol. Sci. 2020; 21: 3861.
21.    Jackson, D. J. et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J. Allergy Clin. Immunol. 2020; 146: 203–206. DOI:
22.    Procko, E. The sequence of human ACE2 is suboptimal for binding the S spike protein of SARS coronavirus 2. BioRxiv (2020). doi: 10.1101/2020.03.16.994236
23.    Crackower, M. A. et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature. 2002; 417: 822–828.
24.    Rahman, M. A. et al. Data-driven dynamic clustering framework for mitigating the adverse economic impact of Covid-19 lockdown practices. Sustain. cities Soc. 2020; 62: 102372.
25.    Arianna Di Stadio, M. D., Ralli, M. and Ricci, G. Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment. Eur Rev Med Pharmacol Sci. 2020; 24: 5195–5196. DOI: 10.26355/eurrev_202005_21298
26.    Bukowska, A. et al. Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men. Exp. Biol. Med. 2017; 242: 1412–1423.
27.    Voigt, E. A. et al. Sex differences in older adults’ immune responses to seasonal influenza vaccination. Front. Immunol. 2019; 10: 180.
28.    Klein, S. L. and Flanagan, K. L. Sex differences in immune responses. Nat. Rev. Immunol. 2016; 16: 626–638.
29.    Tasić, N., Paixão, T. R. L. C. and Gonçalves, L. M. Biosensing of D-dimer, making the transition from the central hospital laboratory to bedside determination. Talanta. 2020; 207: 120270.
30.    Mallapaty, S. and Callaway, E. What scientists do and don’t know about the Oxford-AstraZeneca COVID vaccine. Nature. 2021; 592: 15–17. DOI: 10.1038/d41586-021-00785-7.
31.    Iqbal, Z. and Tanty, G. Impact of Covid on Banking Industry in India. 2021. DOI : 10.5958/2231-0657.2021.00011.2.
32.    Aslan, I., Ochnik, D. and Çınar, O. Exploring perceived stress among students in Turkey during the COVID-19 pandemic. Int. J. Environ. Res. Public Health. 2020; 17: 8961.
33.    Yu, B. et al. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis. J. Thromb. Thrombolysis.  2020; 50: 548–557.
34.    Solanki, R. and Singh, K. Covid 19 home confinement effects on consumer’s food consumption and eating habits. Age (in years) 20, 10 (2021). DOI: 10.52711/2321-5763.2021.00076.
35.    Taneri, P. E. et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. Eur. J. Epidemiol. 2020; 35: 763–773.
36.    Kumar, A. Emotional intelligence can help healthcare professionals and managers: A way deal COVID-19 pandemic. Asian J. Manag. 2021; 12: 353–358. DOI: 10.52711/2321-5763.2021.00053
37.    Chaudhary, N. and Anand, S. Effectiveness of online payment system during COVID-19. Education. 2022; 109: 50–54. DOI: 10.52711/2321-5763.2022.00011.
38.    Koozi, H., Lengquist, M. and Frigyesi, A. C-reactive protein as a prognostic factor in intensive care admissions for sepsis: A Swedish multicenter study. J. Crit. Care. 2020; 56: 73–79.
39.    Vidal-Cevallos, P. et al. Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study. Ann. Hepatol. 2021; 24: 100338. doi: 10.1016/j.aohep.2021.100354.
40.    Vishnu, P. K., Anil, P. V and Vyshak, P. K. Adaptation towards Green banking; exploring acceptance and awareness among stakeholders of Banking Industry; A Post COVID-19 outbreak analysis. Asian J. Manag. 2022; 13: 186–192. DOI: 10.52711/2321-5763.2022.00034.
41.    Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181: 271–280.
42.    Xiang, H.-X. et al. Renal dysfunction and prognosis of COVID-19 patients: a hospital-based retrospective cohort study. BMC Infect. Dis. 2021; 21: 1–7.
43.    Cucinotta, D. and Vanelli, M. WHO declares COVID-19 a pandemic. Acta Bio Medica Atenei Parm. 2020; 91: 157. doi: 10.23750/abm.v91i1.9397.
44.    Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020; 367: 1260–1263.
45.    Vermillion, M. S., Ursin, R. L., Attreed, S. E. and Klein, S. L. Estriol reduces pulmonary immune cell recruitment and inflammation to protect female mice from severe influenza. Endocrinology. 2018; 159: 3306–3320. DOI: 10.1126/science.abb2507.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available